The blood test, Called PanSeer, detected cancer in 91% of people who had been asymptomatic when the samples were collected and were diagnosed with cancer one to four years later.
The prevalence of antibodies for people recovering from a mild cases of COVID-19 dropped precipitously after less than three months, according to a research letter published this week in The New England Journal of Medicine.